These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction. Deguchi I, Horiuchi Y, Hayashi T, Sehara Y, Kato Y, Ohe Y, Fukuoka T, Maruyama H, Sano H, Nagamine Y, Tanahashi N. J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602 [Abstract] [Full Text] [Related]
12. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us? Fabbri G, Maggioni AP. Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394 [Abstract] [Full Text] [Related]
13. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies. Glueck CJ, Aregawi D, Agloria M, Khalil Q, Winiarska M, Munjal J, Gogineni S, Wang P. Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175 [Abstract] [Full Text] [Related]
18. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial. Tam LS, Li EK, Shang Q, Tomlinson B, Lee VW, Lee KK, Li M, Kuan WP, Li TK, Tseung L, Yip GW, Freedman B, Yu CM. Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445 [Abstract] [Full Text] [Related]
19. Effect of intensive lipid-lowering therapy with rosuvastatin on progression of carotid intima-media thickness in Japanese patients: Justification for Atherosclerosis Regression Treatment (JART) study. Nohara R, Daida H, Hata M, Kaku K, Kawamori R, Kishimoto J, Kurabayashi M, Masuda I, Sakuma I, Yamazaki T, Yokoi H, Yoshida M, Justification for Atherosclerosis Regression Treatment (JART) Investigators. Circ J; 2012 Nov; 76(1):221-9. PubMed ID: 22094911 [Abstract] [Full Text] [Related]
20. Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis--the rationale and methodology of the METEOR study. Crouse JR, Grobbee DE, O'Leary DH, Bots ML, Evans GW, Palmer MK, Riley WA, Raichlen JS, Measuring Effects on intima media Thickness: an Evalution Of Rosuvastatin study group. Cardiovasc Drugs Ther; 2004 May; 18(3):231-8. PubMed ID: 15229392 [Abstract] [Full Text] [Related] Page: [Next] [New Search]